Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Mupirocin
MUPIROCIN CALCIUM · 231-791-2 · PSEUDOMONIC ACID · PSEUDOMONIC ACID A · bactroban · L-talo-Non-2-enonic acid, 5,9-anhydro-2,3,4,8-tetradeoxy-8-(2S,3S)-3-(1S,2S)-2-hydroxy-1-methylpropyloxiranylmethyl-3-methyl-, 8-carboxyoctyl ester, (2E)- · Turixi · Turixin

식별자 및 물리적 특성
| CAS No. | 12650-69-0 |
|---|---|
| 분자식 | C26H44O9 |
| 평균 분자량 | 500.6 g/mol |
| 단동위원소 질량 | 500.29853299 g/mol |
| SMILES | C/C(=C\C(=O)OCCCCCCCCC(=O)O)C[C@@H]1OC[C@H](C[C@@H]2O[C@H]2[C@@H](C)[C@H](C)O)[C@@H](O)[C@H]1O |
| InChIKey | MINDHVHHQZYEEK-HBBNESRFSA-N |
| PubChem CID | 446596 |
| ChEMBL | CHEMBL719 |
| ChEBI | CHEBI:7025 |
| EC No. | 603-145-3 |
| DTXSID | DTXSID0046438 |
화학 및 물리적 성질
| XLogP | 3 |
|---|---|
| 극성 표면적 | 146 |
| 수소 결합 공여자 수 | 4 |
| 수소 결합 수용자 수 | 9 |
| 회전 가능 결합 수 | 17 |
| 무거운 원자 수 | 35 |
| 형식 전하 | 0 |
| 복잡도 | 694 |
| 의약품 | Pharmaceuticals -> Listed in ZINC15Pharmaceuticals -> Antibiotics |
| 용해도 | 2.65e-02 g/LH2O: 12 mg/mL, 가용성 |
| Human Drugs | Breast FeedingLactationMilk, HumanAnti-Infective Agents, LocalAntibacterial AgentsFDA approved drugs -> Active ingredientDermatological medicines > Anti-infective medicines |
| Animal Drugs | Active Ingredients (Mupirocin) -> FDA Greenbook |
| 녹는점 | 77-7877 - 78 °C77-780C |
| Physical Description | Solid |
| Collision Cross Section | 215.12 Ų [M+Na]+ [CCS Type: TWMethod: calibrated with polyalanine and drug standards]214.8 Ų [M+H]+ [CCS Type: TW |
| 끓는 점 | 672℃ |
| 밀도 | 1.183±0.06 g/cm3(Predicted) |
| 인화점 | >110°(230°F) |
| 저장 조건 | Inert atmosphere,Store in freezer, under -20°C |
| 물리적 상태 | 고체 |
| pKa(산도 계수) | 4.78±0.10(Predicted) |
| 색상 | 흰색에서 황갈색까지 |
| 용해도 | DMSO 또는 메탄올에 용해됩니다. 물에 거의 녹지 않음 |
| Merck | 14,6302 |
| 안정성 | 제공된 대로 구매일로부터 1년 동안 안정적입니다. DMSO의 솔루션은 -20°C에서 최대 1개월 동안 보관할 수 있습니다. |
| 주요 응용 | 제약 |
| InChIKey | MINDHVHHQZYEEK-HBBNESRFSA-N |
| SMILES | [H][C@@]1(CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]1O)C[C@@H]2O[C@@]2([H])[C@@H](C)[C@H](C)O |
화학적 성질
White Crystalline Solid
안전 및 규제
| GHS 분류 | This chemical does not meet GHS hazard criteria for 25% (1 of 4) of reports.WarningH302 (25%): Harmful if swallowed [Warning Acute toxicity, oral]P261, P264, P264+P265, P270, P272, P280, P301+P317, P302+P352, P305+P351+P338, P321, P330, P332+P317, P333+P317, P337+P317, P362+P364, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 4 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. |
|---|---|
| 규제 정보 | Mupirocin: Does not have an individual approval but may be used under an appropriate group standard |
| Hazard Classes and Categories | Acute Tox. 4 (25%) |
| 유해 작용 | Adverse Drug Reactions |
| 독성 요약 | Currently, no available study or report suggests that using topical mupirocin consistently causes systemic toxicity. As previously stated, caution is advised in individuals with severe renal impairment and those with large open wounds due to the potential for increased absorption and nephrotoxicity. In such cases, renal function should be closely monitored with scheduled renal function panels, as stated in the FDA guidelines for Bactroban. |
| Effects During Pregnancy and Lactation | ◉ Summary of Use during Lactation |
| 수질 위해 등급(WGK) | 2 |
| RTECS 번호 | RA6907000 |
| 관세 코드 | 2941906000 |
| 저장 분류 | 11 - Combustible Solids |
용도
개요
Mupirocin (pseudomonic acid A) is an antibiotic produced by Pseudomonas fluorescens. It is useful in the treatment of dermal infections, especially those involving S. aureus and S. epidermidis.
용도
Mupirocin, is a major component of the pseudomonic acid, an antibiotic complex produced by Pseudomonas fluorescens NCIB 10586. Topical antibacterial.